New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
— February 16, 2019A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine. The therapeutic approach involves modifying human platelets to create “decoys” that are still capable of binding to some cells but will not aggregate or carry out the […]
Continue Reading ...